Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Itziar Oyagüez

Cost Analysis of the Management of Brain Metastases in Patients With Advanced ALK+ NSCLC: Alectinib Versus Crizotinib

Lung Cancer Management

English

Related publications

Pcn172 - Cost-Effectiveness Analysis of Alectinib in Untreated Alk-Rearranged NSCLC Italian Patients

Value in Health

Occupational Health

English

Alectinib Provides a New Option for ALK-positive NSCLC Patients After Progression on Crizotinib

Journal of Community and Supportive Oncology

English

The Potential Role of HGF-MET Signaling and Autophagy in the War of Alectinib Versus Crizotinib Against ALK-positive NSCLC

Journal of Experimental and Clinical Cancer Research

Cancer Research

English

P044 Cost-Effectiveness Analysis of Icotinib vs Whole-Brain Irradiation in NSCLC Patients With Brain Metastases

Journal of Thoracic Oncology

Respiratory Medicine

English

P1.01-39 Cost-Effectiveness of Crizotinib Versus Chemotherapy as First-Line Treatment of ALK Positive Advanced NSCLC -- A Real World Study

Journal of Thoracic Oncology

Respiratory Medicine

English

Pcn82 - Budget Impact Analysis of Alectinib for the Treatment of Patients With Untreated Alk-Rearranged NSCLC in Italy

Value in Health

Occupational Health

English

P1.01-30 Crizotinib in Advanced Non-Adenocarcinoma, NSCLC (NA-NSCLC) Patients With ALK Rearrangement: A Retrospective Study and Literature Review

Journal of Thoracic Oncology

Respiratory Medicine

English

PL02.03 Brigatinib vs Crizotinib in Patients With ALK Inhibitor-Naive Advanced ALK+ NSCLC: First Report of a Phase 3 Trial (ALTA-1L)

Journal of Thoracic Oncology

Respiratory Medicine

English

Crizotinib-Associated Toxic Epidermal Necrolysis in an ALK-positive Advanced NSCLC Patient

Molecular and Clinical Oncology

Cancer Research

English